Risk factors to port-a-cat damage/removal in patients in antineoplastic chemotherapy: a retrospective observational study
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Journal of Health & Biological Sciences |
Texto Completo: | https://periodicos.unichristus.edu.br/jhbs/article/view/4340 |
Resumo: | Objective: To identify the prevalence and risk factors for damage or removal of fully implanted long-term catheters from patients undergoing antineoplastic chemotherapy. Methods: This is an observational, cross-sectional study that evaluated medical records of patients undergoing placement of a fully implanted catheter for antineoplastic chemotherapy from January 2015 to December 2019. Clinical and sociodemographic data were collected that were associated with catheter survival using Log-Rank Mantel-Cox and Cox Regression tests (SPSS, p<0.05). Results: Of 58 devices evaluated, most patients were higher educated married females, younger than 60 years old. The most frequent side of catheter implantation was the right side, and the most prevalent implantation site was the internal jugular vein. Less than 1/3 of patients (29.3%) had port-a-cath loss due to complications with a five-year follow-up survival of 35.73±3.76 (95% CI = 28.35-43.11). Two patients (4.7%) needed removal due to device exposure, three (7.0%) due to obstruction, and 12 (27.9%) due to infection. Female patients (p=0.019) and patients with breast tumors (p=0.049) had a shorter mean survival time. The women showed port-a-cath survival 9.25 times (95% CI = 1.35-50.25) shorter in the multivariate analysis. Conclusion: port-a-cath catheter loss is around 30% and being female is a determining risk factor. |
id |
CHRISTUS-1_da0ce9c4d4c2cadeda5feae2aee31e20 |
---|---|
oai_identifier_str |
oai:ojs.emnuvens.com.br:article/4340 |
network_acronym_str |
CHRISTUS-1 |
network_name_str |
Journal of Health & Biological Sciences |
repository_id_str |
|
spelling |
Risk factors to port-a-cat damage/removal in patients in antineoplastic chemotherapy: a retrospective observational studyVascular Access DevicesAntineoplastic AgentsComplications. Peripherally Inserted Central CatheterRisk FactorsObjective: To identify the prevalence and risk factors for damage or removal of fully implanted long-term catheters from patients undergoing antineoplastic chemotherapy. Methods: This is an observational, cross-sectional study that evaluated medical records of patients undergoing placement of a fully implanted catheter for antineoplastic chemotherapy from January 2015 to December 2019. Clinical and sociodemographic data were collected that were associated with catheter survival using Log-Rank Mantel-Cox and Cox Regression tests (SPSS, p<0.05). Results: Of 58 devices evaluated, most patients were higher educated married females, younger than 60 years old. The most frequent side of catheter implantation was the right side, and the most prevalent implantation site was the internal jugular vein. Less than 1/3 of patients (29.3%) had port-a-cath loss due to complications with a five-year follow-up survival of 35.73±3.76 (95% CI = 28.35-43.11). Two patients (4.7%) needed removal due to device exposure, three (7.0%) due to obstruction, and 12 (27.9%) due to infection. Female patients (p=0.019) and patients with breast tumors (p=0.049) had a shorter mean survival time. The women showed port-a-cath survival 9.25 times (95% CI = 1.35-50.25) shorter in the multivariate analysis. Conclusion: port-a-cath catheter loss is around 30% and being female is a determining risk factor.UNICHRISTUS2022-12-30info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionPeer ReviewRevisado por paresAvaliado por Paresapplication/pdfhttps://periodicos.unichristus.edu.br/jhbs/article/view/434010.12662/2317-3076jhbs.v10i1.4340.p1-7.2022Journal of Health & Biological Sciences; Vol. 10 No. 1 (2022): Journal of Health and Biological Sciences; 1-7Journal of Health and Biological Sciences; Vol. 10 Núm. 1 (2022): Journal of Health and Biological Sciences; 1-7Journal of Health & Biological Sciences; v. 10 n. 1 (2022): Journal of Health and Biological Sciences; 1-72317-30762317-308410.12662/2317-3076jhbs.v10i1.2022reponame:Journal of Health & Biological Sciencesinstname:Centro Universitário Christus (Unichristus)instacron:CHRISTUSenghttps://periodicos.unichristus.edu.br/jhbs/article/view/4340/1690Copyright (c) 2022 Journal of Health & Biological Sciencesinfo:eu-repo/semantics/openAccessLima, Karen Rayara BezerraPerdigão, Marcela Maria de MeloMatos Carlos, Anna Clara Aragãode Alencar, Manuele Carine MacielNobrega, Cássia Emanuella MaltaSilva, Paulo Goberlânio de Barros2023-09-29T20:39:16Zoai:ojs.emnuvens.com.br:article/4340Revistahttps://periodicos.unichristus.edu.br/jhbs/indexPRIhttps://periodicos.unichristus.edu.br/jhbs/oaisecretaria.jhbs@unichristus.edu.br || editor.jhbs@fchristus.edu.br2317-30762317-3084opendoar:2023-09-29T20:39:16Journal of Health & Biological Sciences - Centro Universitário Christus (Unichristus)false |
dc.title.none.fl_str_mv |
Risk factors to port-a-cat damage/removal in patients in antineoplastic chemotherapy: a retrospective observational study |
title |
Risk factors to port-a-cat damage/removal in patients in antineoplastic chemotherapy: a retrospective observational study |
spellingShingle |
Risk factors to port-a-cat damage/removal in patients in antineoplastic chemotherapy: a retrospective observational study Lima, Karen Rayara Bezerra Vascular Access Devices Antineoplastic Agents Complications. Peripherally Inserted Central Catheter Risk Factors |
title_short |
Risk factors to port-a-cat damage/removal in patients in antineoplastic chemotherapy: a retrospective observational study |
title_full |
Risk factors to port-a-cat damage/removal in patients in antineoplastic chemotherapy: a retrospective observational study |
title_fullStr |
Risk factors to port-a-cat damage/removal in patients in antineoplastic chemotherapy: a retrospective observational study |
title_full_unstemmed |
Risk factors to port-a-cat damage/removal in patients in antineoplastic chemotherapy: a retrospective observational study |
title_sort |
Risk factors to port-a-cat damage/removal in patients in antineoplastic chemotherapy: a retrospective observational study |
author |
Lima, Karen Rayara Bezerra |
author_facet |
Lima, Karen Rayara Bezerra Perdigão, Marcela Maria de Melo Matos Carlos, Anna Clara Aragão de Alencar, Manuele Carine Maciel Nobrega, Cássia Emanuella Malta Silva, Paulo Goberlânio de Barros |
author_role |
author |
author2 |
Perdigão, Marcela Maria de Melo Matos Carlos, Anna Clara Aragão de Alencar, Manuele Carine Maciel Nobrega, Cássia Emanuella Malta Silva, Paulo Goberlânio de Barros |
author2_role |
author author author author author |
dc.contributor.author.fl_str_mv |
Lima, Karen Rayara Bezerra Perdigão, Marcela Maria de Melo Matos Carlos, Anna Clara Aragão de Alencar, Manuele Carine Maciel Nobrega, Cássia Emanuella Malta Silva, Paulo Goberlânio de Barros |
dc.subject.por.fl_str_mv |
Vascular Access Devices Antineoplastic Agents Complications. Peripherally Inserted Central Catheter Risk Factors |
topic |
Vascular Access Devices Antineoplastic Agents Complications. Peripherally Inserted Central Catheter Risk Factors |
description |
Objective: To identify the prevalence and risk factors for damage or removal of fully implanted long-term catheters from patients undergoing antineoplastic chemotherapy. Methods: This is an observational, cross-sectional study that evaluated medical records of patients undergoing placement of a fully implanted catheter for antineoplastic chemotherapy from January 2015 to December 2019. Clinical and sociodemographic data were collected that were associated with catheter survival using Log-Rank Mantel-Cox and Cox Regression tests (SPSS, p<0.05). Results: Of 58 devices evaluated, most patients were higher educated married females, younger than 60 years old. The most frequent side of catheter implantation was the right side, and the most prevalent implantation site was the internal jugular vein. Less than 1/3 of patients (29.3%) had port-a-cath loss due to complications with a five-year follow-up survival of 35.73±3.76 (95% CI = 28.35-43.11). Two patients (4.7%) needed removal due to device exposure, three (7.0%) due to obstruction, and 12 (27.9%) due to infection. Female patients (p=0.019) and patients with breast tumors (p=0.049) had a shorter mean survival time. The women showed port-a-cath survival 9.25 times (95% CI = 1.35-50.25) shorter in the multivariate analysis. Conclusion: port-a-cath catheter loss is around 30% and being female is a determining risk factor. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-12-30 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Peer Review Revisado por pares Avaliado por Pares |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://periodicos.unichristus.edu.br/jhbs/article/view/4340 10.12662/2317-3076jhbs.v10i1.4340.p1-7.2022 |
url |
https://periodicos.unichristus.edu.br/jhbs/article/view/4340 |
identifier_str_mv |
10.12662/2317-3076jhbs.v10i1.4340.p1-7.2022 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://periodicos.unichristus.edu.br/jhbs/article/view/4340/1690 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2022 Journal of Health & Biological Sciences info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2022 Journal of Health & Biological Sciences |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
UNICHRISTUS |
publisher.none.fl_str_mv |
UNICHRISTUS |
dc.source.none.fl_str_mv |
Journal of Health & Biological Sciences; Vol. 10 No. 1 (2022): Journal of Health and Biological Sciences; 1-7 Journal of Health and Biological Sciences; Vol. 10 Núm. 1 (2022): Journal of Health and Biological Sciences; 1-7 Journal of Health & Biological Sciences; v. 10 n. 1 (2022): Journal of Health and Biological Sciences; 1-7 2317-3076 2317-3084 10.12662/2317-3076jhbs.v10i1.2022 reponame:Journal of Health & Biological Sciences instname:Centro Universitário Christus (Unichristus) instacron:CHRISTUS |
instname_str |
Centro Universitário Christus (Unichristus) |
instacron_str |
CHRISTUS |
institution |
CHRISTUS |
reponame_str |
Journal of Health & Biological Sciences |
collection |
Journal of Health & Biological Sciences |
repository.name.fl_str_mv |
Journal of Health & Biological Sciences - Centro Universitário Christus (Unichristus) |
repository.mail.fl_str_mv |
secretaria.jhbs@unichristus.edu.br || editor.jhbs@fchristus.edu.br |
_version_ |
1797052854083518464 |